These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1153991)
1. [Editorial: To measure or not to measure--that is the question. Problems of measuring blood levels of drugs]. Preisig R; Bircher J Schweiz Med Wochenschr; 1975 Jul; 105(30):933-5. PubMed ID: 1153991 [No Abstract] [Full Text] [Related]
2. [Interest in the determination of drugs and their metabolites in clinical pharmacology and therapeutics]. Olive G Ann Biol Clin (Paris); 1975; 33(3):171-4. PubMed ID: 1200436 [No Abstract] [Full Text] [Related]
3. Clinical pharmacokinetics: the pharmacological monitoring of plasmatic levels in therapy. Bonora MR; Guaglio R; Terzoni PA; Rondanelli R Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):73-87. PubMed ID: 7372379 [TBL] [Abstract][Full Text] [Related]
4. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites. Wosilait WD Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500 [No Abstract] [Full Text] [Related]
5. Errors in measuring drug concentrations. McCormick W; Ingelfinger JA; Isakson G; Goldman P N Engl J Med; 1978 Nov; 299(20):1118-21. PubMed ID: 703790 [No Abstract] [Full Text] [Related]
7. Plasma concentrations of drugs as a guide to therapy in clinical practice. Kelly JG; O'Malley K Ir Med J; 1978 Nov; 71(17):578-82. PubMed ID: 721412 [No Abstract] [Full Text] [Related]
8. Pharmacodynamic and pharmacokinetic measurements in cardiovascular-renal drugs. Hayes AH Clin Pharmacol Ther; 1974 Jul; 16(1):201-11. PubMed ID: 4843316 [No Abstract] [Full Text] [Related]
10. Measurement of therapeutic agents in blood. Marks V; Lindup WE; Baylis EM Adv Clin Chem; 1973; 16():47-109. PubMed ID: 4589494 [No Abstract] [Full Text] [Related]
11. [Problems in use of anti-epileptics. 1. Relationship between dosage, blood level and effect]. Daute KH; Fürst W; Lauterbach H; Klust E; Falk M Pharmazie; 1974 Dec; 29(12):780-3. PubMed ID: 4460006 [No Abstract] [Full Text] [Related]
12. Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences. Jatlow P Am J Clin Pathol; 1973 Feb; 59(2):167-73. PubMed ID: 4119926 [No Abstract] [Full Text] [Related]
13. Therapeutic drug monitoring in childhood. Buchanan N Aust Paediatr J; 1986 Feb; 22(1):19-26. PubMed ID: 3087337 [No Abstract] [Full Text] [Related]
14. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin. Schumacher GE Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals. Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M J Pharmacol Exp Ther; 1981 Jun; 217(3):805-11. PubMed ID: 7230008 [TBL] [Abstract][Full Text] [Related]
16. Transport of drugs, hormones and fatty acids in lipemic serum. Rudman D; Hollins B; Bixler TJ; Mosteller RC J Pharmacol Exp Ther; 1972 Mar; 180(3):797-810. PubMed ID: 4111068 [No Abstract] [Full Text] [Related]
17. The effect of hyperlipidemia on therapeutic drug assays. Baer DM; Paulson RA Ther Drug Monit; 1987; 9(1):72-7. PubMed ID: 3554630 [TBL] [Abstract][Full Text] [Related]
18. Clinical monitoring of therapeutic drugs. Marks V Ann Clin Biochem; 1979 Nov; 16(6):370-9. PubMed ID: 395889 [No Abstract] [Full Text] [Related]
19. Drug interferences with plasma assays in therapeutic drug monitoring. Yosselson-Superstine S Clin Pharmacokinet; 1984; 9(1):67-87. PubMed ID: 6362953 [TBL] [Abstract][Full Text] [Related]